---
figid: PMC8364652__jcav12p5543g006
figtitle: Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Helicobacter pylori
- Saimiriine gammaherpesvirus 2
- Alpinia officinarum
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC8364652
filename: jcav12p5543g006.jpg
figlink: /pmc/articles/PMC8364652/figure/F6/
number: F6
caption: ROS utilize the antioxidant system, DNA damage repair pathway, and metabolic
  reprogramming to inhibit the accumulation of ROS and repair ROS-induced damage.
  ROS activate NRF2, thereby promoting the expression of NQO1, CAT, SOD1/2 and PRDX1/3,
  and decreasing ROS levels. ROS activate the expression of KLF14 via the PI3K/Akt,
  p42/p44 MAPK, AMPK, and PKC pathways; KLF14 then couples with p300 and CBP, and
  promotes the expression of HO-1, which restores cellular redox balance. ROS accumulation
  inhibits PKM2, thus leading to G-6-P flux into the PPP and generating sufficient
  NADPH to produce GSH, thereby maintaining ROS homeostasis. ROS trigger LIPG upregulation
  and induce the lipolysis of extracellular lipoproteins to compensate for the ROS-impeded
  fatty acid synthesis pathway. The upregulated LIPG also protects against oxidative
  damage via the accumulation of intracellular lipid droplets. ROS activate KRAS/AMPK
  signaling, thus inducing metabolic reprogramming toward aerobic glycolysis. ROS
  activate ATM, which in turn phosphorylates BRCA1 and triggers HR for DNA repair
  and activation of P53, which in turn triggers the NER pathway. ROS activate the
  ATM-chk2 and ATR-chk1 axis, thereby causing cell cycle arrest of cancer cells, preventing
  the cells from undergoing mitosis and favoring DNA repair. NQO1, NADH dehydrogenase,
  quinone 1; CAT, catalase; PKC, protein kinase C; G-6-P, glucose-6-phosphate; PPP,
  pentose phosphate pathway.
papertitle: Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy.
reftext: Run Huang, et al. J Cancer. 2021;12(18):5543-5561.
year: '2021'
doi: 10.7150/jca.54699
journal_title: Journal of Cancer
journal_nlm_ta: J Cancer
publisher_name: Ivyspring International Publisher
keywords: reactive oxygen species | cancer | pro-tumor | anti-cancer | self-adaption
  system | therapy
automl_pathway: 0.9416863
figid_alias: PMC8364652__F6
figtype: Figure
redirect_from: /figures/PMC8364652__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8364652__jcav12p5543g006.html
  '@type': Dataset
  description: ROS utilize the antioxidant system, DNA damage repair pathway, and
    metabolic reprogramming to inhibit the accumulation of ROS and repair ROS-induced
    damage. ROS activate NRF2, thereby promoting the expression of NQO1, CAT, SOD1/2
    and PRDX1/3, and decreasing ROS levels. ROS activate the expression of KLF14 via
    the PI3K/Akt, p42/p44 MAPK, AMPK, and PKC pathways; KLF14 then couples with p300
    and CBP, and promotes the expression of HO-1, which restores cellular redox balance.
    ROS accumulation inhibits PKM2, thus leading to G-6-P flux into the PPP and generating
    sufficient NADPH to produce GSH, thereby maintaining ROS homeostasis. ROS trigger
    LIPG upregulation and induce the lipolysis of extracellular lipoproteins to compensate
    for the ROS-impeded fatty acid synthesis pathway. The upregulated LIPG also protects
    against oxidative damage via the accumulation of intracellular lipid droplets.
    ROS activate KRAS/AMPK signaling, thus inducing metabolic reprogramming toward
    aerobic glycolysis. ROS activate ATM, which in turn phosphorylates BRCA1 and triggers
    HR for DNA repair and activation of P53, which in turn triggers the NER pathway.
    ROS activate the ATM-chk2 and ATR-chk1 axis, thereby causing cell cycle arrest
    of cancer cells, preventing the cells from undergoing mitosis and favoring DNA
    repair. NQO1, NADH dehydrogenase, quinone 1; CAT, catalase; PKC, protein kinase
    C; G-6-P, glucose-6-phosphate; PPP, pentose phosphate pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Keap1
  - Nfe2l2
  - Akt1
  - Pik3r1
  - Ep300
  - Klf14
  - Sp6
  - Crebbp
  - Pag1
  - Cytip
  - Hmox1
  - Nq1
  - Cat
  - cac
  - Mip
  - Trpv6
  - Glyat
  - Sod1
  - Sod2
  - Prdx1
  - Prdx3
  - Pkm
  - Decr1
  - Lipg
  - Kras
  - Atm
  - Tpm1
  - Brca1
  - Trp53
  - Prkcg
  - Prkaa2
  - Pik3cg
  - Nqo1
  - Kcnk13
  - Tp53
  - Ccne1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - KEAP1
  - NFE2L2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EP300
  - KLF14
  - SP6
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - HMOX1
  - NQO1
  - CAT
  - CRAT
  - GLYAT
  - SOD1
  - SOD2
  - SOD2-OT1
  - PRDX1
  - PRDX3
  - HMOX2
  - PKM
  - PKLR
  - DECR1
  - LIPG
  - KRAS
  - NRAS
  - ATM
  - BRCA1
  - TP53
  - TP63
  - TP73
  - NR1H2
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - SNF4Agamma
  - AMPKalpha
  - MKP-4
  - p38b
  - rl
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - osa
  - nej
  - CBP
  - eIF4E1
  - Ho
  - Ca-alpha1T
  - ChAT
  - sv
  - Jafrac1
  - G6P
  - amon
  - tefu
  - p53
  - betaTub60D
  - hth
  - CycE
  - cyc
  - keap1a
  - nfe2l2a
  - zgc:153115
  - nqo1
  - cat
  - sod1
  - sod2
  - prdx1
  - prdx2
  - prdx3
  - pkma
  - lipg
  - kras
  - atm
  - tp53
---
